FibroBiologics Total Liabilities

The latest total liabilities for FBLG is $3.3M as of June 2026. That compares with $13M in the prior-year period — down 74.8% year over year. Investors often review this figure alongside FibroBiologics's historical trend and sector peers before judging valuation or financial health.

Over the past year, FBLG's total liabilities moved from $13M to $3.3M — a 74.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in FibroBiologics's operating scale or balance-sheet position.

A total liabilities figure of $3.3M for FBLG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FBLG's total liabilities ($3.3M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.